Oxaliplatin Elicits Improved Survival in Select Patients with Stage III CRC
Written by
Cancer Network
Published
0
comments
0
min
Significantly improved survival was observed with oxaliplatin among patients 60 to 70 years of age with stage III CRC, but not those older than 70 years.